Cargando…
Targeting oncogenic Notch signaling with SERCA inhibitors
P-type ATPase inhibitors are among the most successful and widely prescribed therapeutics in modern pharmacology. Clinical transition has been safely achieved for H(+)/K(+) ATPase inhibitors such as omeprazole and Na(+)/K(+)-ATPase inhibitors like digoxin. However, this is more challenging for Ca(2+...
Autores principales: | Pagliaro, Luca, Marchesini, Matteo, Roti, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789735/ https://www.ncbi.nlm.nih.gov/pubmed/33407740 http://dx.doi.org/10.1186/s13045-020-01015-9 |
Ejemplares similares
-
Targeting Notch Trafficking and Processing in Cancers
por: Pagliaro, Luca, et al.
Publicado: (2020) -
Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies
por: Sorrentino, Claudia, et al.
Publicado: (2019) -
Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia
por: Follini, Elena, et al.
Publicado: (2019) -
Oncogenic and Tumor-Suppressive Functions of NOTCH Signaling in Glioma
por: Parmigiani, Elena, et al.
Publicado: (2020) -
Notch signalling pathway as an oncogenic factor involved in cancer development
por: Brzozowa-Zasada, Marlena, et al.
Publicado: (2016)